About Megan Heaps

Articles by Megan Heaps

Relapsed Follicular Lymphoma: Treatment Options and What to Expect
Apr 15, 2026
How Nutrition, Movement, and Stress Management Can Support Your Myeloma Treatment
Mar 31, 2026
Predicting the Risk of Lymphoma Relapse: Latest Research
Mar 28, 2026
Axi-cel vs Liso-cel CAR T-cell Therapy as Second LBCL Treatments
Mar 27, 2026
Tafasitamab with Lenalidomide and Rituximab for Relapsed Follicular Lymphoma
Mar 26, 2026
Living with Cancer: Lessons From Jason Mook’s Unshaken Story
Mar 26, 2026
Is CLL an Autoimmune Disease? How CLL Affects the Immune System
Mar 24, 2026
U.S. FDA Approves Nivolumab (Opdivo) with AVD for Classical Hodgkin Lymphoma
Mar 24, 2026
Bispecific Antibodies for Lymphoma: What Patients Need to Know
Mar 19, 2026
Bispecific Antibodies for Older Adults with Aggressive B-cell Lymphomas
Mar 18, 2026
Lymphoma PET/CT Scan: How It Works and What Patients Can Expect
Mar 17, 2026
Myeloma Updates from Dr. Craig Cole
Mar 16, 2026
Blood Clot and Bleeding Risk in B-cell Lymphomas: Gene Changes and CAR T-cell Therapy Insights
Mar 13, 2026
How AI and Genetic Testing Are Improving Lymphoma Classification and Relapse Insights
Mar 12, 2026
What Is Myeloma Cast Nephropathy? Myeloma Kidney Risks and Treatment Options
Mar 06, 2026
$Axi-cel Plus Rituximab for Refractory LBCL image$

Axi-cel Plus Rituximab for Refractory LBCL
Mar 05, 2026
$U.S. FDA Approves Teclistamab (Tecvayli) with Daratumumab (Darzalex Faspro) for Relapsed or Refractory Multiple Myeloma image$

U.S. FDA Approves Teclistamab (Tecvayli) with Daratumumab (Darzalex Faspro) for Relapsed or Refractory Multiple Myeloma
Mar 05, 2026
A New Risk Score May Improve Predicting Mantle Cell Lymphoma Outcomes
Mar 04, 2026
A Specialist’s Answers for Common CLL Questions: Treatment Timing, Therapy Options, Handling Watch-and-Wait, and More
Mar 02, 2026
Does Treatment Order of CAR T-cell Therapy and Bispecific Antibodies Matter for LBCL?
Feb 26, 2026
BTK Degrader Updates for CLL from ASH 2025
Feb 25, 2026
ASH 2025: BTK Inhibitor Updates for High-Risk LBCL
Feb 24, 2026
February Is Cancer Prevention Month: Small Steps That Can Help Lower Cancer Risk
Feb 17, 2026
ASH 2025: New Treatments for Richter Transformation
Feb 03, 2026